On today’s episode, we char with Dr. Prasun Mishra. Dr. Mishra (Ex-Genentech, Ex-NCI, Ex-NIH) is the Founder and CEO of Agility Pharmaceuticals. He is a serial entrepreneur who founded his first company after graduating high school, and second company during his PhD. Since then, he has accumulated a wealth of experienced by building, investing and advising numerous other companies. He is an investor/ co-founder/ board member of a few US based corporations focused on accelerating drug discovery & development, blockchain & digital health. Dr. Mishra is also founding president & CEO of American Association for Precision Medicine (AAPM) and is leading research efforts focused on preventing & curing chronic diseases; not only treating the sick but also providing knowledge/tools to individuals to live longer, healthier lives. In this episode, you’ll learn: What is precision medicine? How is Big Data Analytics, AI and technology impacting the medical industry? Is the current process for drug discovery broken and if so, how can it be fixed? Will technology be at a point where research can be one step ahead of possible mutations in viruses or drug resistances? What does all this new technology mean for the skill requirements of health professionals? We would also like to thank Atul Padha who made the introduction that allowed today’s interview to take place. BOOKS AND RESOURCES Download yourfree audiobook at Audible. Find the best job candidate at Ziprecruiter. Find Dr. Mishra LinkedIn Email Mishra American Association of Precision Medicine CONNECT WITH SHAWN: https://linktr.ee/ShawnflynnSV Shawn Flynn’s Twitter Account Shawn Flynn’s LinkedIn Account Silicon Valley LinkedIn Group Account Shawn Flynn’s Facebook Account Email [email protected]

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related